Aurinia Pharmaceuticals, Inc. (AUPH)
16.37
-0.18
(-1.09%)
USD |
NASDAQ |
Oct 13, 16:00
16.37
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash and Short Term Investments (Quarterly) : 443.12M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 443.12M |
| March 31, 2026 | 378.78M |
| December 31, 2025 | 398.00M |
| September 30, 2025 | 351.81M |
| June 30, 2025 | 315.13M |
| March 31, 2025 | 312.90M |
| December 31, 2024 | 358.48M |
| September 30, 2024 | 348.75M |
| June 30, 2024 | 330.48M |
| March 31, 2024 | 319.91M |
| December 31, 2023 | 350.49M |
| September 30, 2023 | 337.90M |
| June 30, 2023 | 350.71M |
| March 31, 2023 | 361.53M |
| December 31, 2022 | 389.39M |
| September 30, 2022 | 376.64M |
| June 30, 2022 | 391.74M |
| March 31, 2022 | 418.75M |
| December 31, 2021 | 466.08M |
| September 30, 2021 | 286.40M |
| June 30, 2021 | 318.74M |
| March 31, 2021 | 348.26M |
| December 31, 2020 | 398.33M |
| September 30, 2020 | 392.04M |
| June 30, 2020 | 264.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 286.12M |
| December 31, 2019 | 306.02M |
| September 30, 2019 | 134.54M |
| June 30, 2019 | 131.49M |
| March 31, 2019 | 144.33M |
| December 31, 2018 | 125.86M |
| September 30, 2018 | 138.88M |
| June 30, 2018 | 150.20M |
| March 31, 2018 | 159.13M |
| December 31, 2017 | 173.46M |
| September 30, 2017 | 182.41M |
| June 30, 2017 | 189.79M |
| March 31, 2017 | 202.12M |
| December 31, 2016 | 39.65M |
| September 30, 2016 | 15.38M |
| June 30, 2016 | 12.12M |
| March 31, 2016 | 10.53M |
| December 31, 2015 | 15.75M |
| September 30, 2015 | 20.58M |
| June 30, 2015 | 25.74M |
| March 31, 2015 | 29.04M |
| December 31, 2014 | 32.70M |
| September 30, 2014 | 35.53M |
| June 30, 2014 | 39.09M |
| March 31, 2014 | 43.29M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | 266.40M |
| Medicus Pharma Ltd. | 10.70M |
| Xenon Pharmaceuticals, Inc. | 930.69M |
| Psyence Biomedical Ltd. | 7.197M |
| Agenus, Inc. | 18.74M |